Profiling Trace Volatile Compounds in Blood by Gas Chromatograph Mass Spectrometry with Dynamic Headspace Extraction

Significance of the Topic

The profiling of volatile compounds in blood has emerged as a critical tool in metabolomics and clinical research. These trace volatiles may form adducts with biomolecules or act as secondary messengers, influencing inflammatory pathways, oxidative stress responses and disease phenotypes. Accurate detection and quantification of these compounds can facilitate early diagnosis, biomarker discovery and monitoring of conditions such as diabetes, cancer, and inflammatory bowel disease.

Study Objectives and Overview

This study compared two headspace extraction methods—static headspace solid-phase micro-extraction (HS-SPME) and dynamic headspace (DHS)—followed by gas chromatography-mass spectrometry (GC-MS) analysis of volatile organic compounds in blood. Key aims were to:

• Assess detection sensitivity and range for a 50-component standard mixture.
• Validate the DHS-GC-MS method at low ng/mL levels.
• Demonstrate the approach on plasma from IL-10 knockout mice, a Crohn’s disease model.

Methodology and Instrumentation

Sample Preparation:

• Standard mixture of 50 volatiles at 100 ng/µL in acetone, spiked into phosphate‐buffered saline with potassium carbonate.
• Mouse plasma (control and IL-10 knockout groups) treated with buffer, salt and internal standard (hexa-fluoro-2-propanol).

HS-SPME Conditions:

• Fiber: DVB/CAR/PDMS, 50/30 μm, exposed at 50 °C for 5 minutes.
• Thermal desorption at 280 °C, splitless injection.

DHS-GC-MS Conditions:

• Headspace sampler HS-20Trap with Tenax GR adsorbent, purge at 50 °C.
• GC: InertCap 5MS/NP or WAX-HT columns, temperature program from 50 °C to 230 °C.
• MS: GCMS-TQ8030, scan m/z 35–300 and SIM modes, interface at 230 °C.

Main Results and Discussion

Comparison of HS-SPME versus DHS:

• DHS detected all 50 standard volatiles, including low-boiling alcohols poorly recovered by HS-SPME.
• Signal areas for alcohols were up to tenfold higher with DHS, with mean RSD of 8 % versus 20 % for HS-SPME.

Method Validation of DHS-GC-MS:

• Linearity (R2>0.99) over 0–100 ng/mL for most compounds.
• Limits of detection down to 0.06–1.97 ng/mL, depending on analyte.
• Intraday precision <10 % RSD and recoveries of 85–147 % in spiked plasma.

Mouse Plasma Application:

• Forty volatile compounds, including aldehydes, ketones, alcohols and furans, were detected.
• Fifteen compounds showed significant differences between controls and IL-10 knockout mice.

Benefits and Practical Applications

The DHS-GC-MS approach offers:

• Enhanced sensitivity for a broad range of volatiles, especially polar alcohols.
• Comprehensive profiling in complex biological matrices.
• Potential for biomarker discovery in clinical diagnostics and metabolic research.

Future Trends and Potential Applications

Advances in dynamic headspace automation and integration with high-throughput GC-MS will enable large-scale clinical studies. Coupling DHS with tandem mass spectrometry and data-driven metabolomics workflows may reveal novel disease signatures. Further miniaturization could lead to point-of-care breath or blood volatile analysis.

Conclusion

DHS-GC-MS significantly outperforms HS-SPME in sensitivity and range for volatile profiling in blood. The validated method reliably detects ng/mL levels of diverse compounds and reveals disease-related changes in an IL-10 knockout mouse model. This platform holds promise for clinical research and biomarker development.

References

M. Yoshida et al. Multi-Component Profiling of Trace Volatiles in Blood by Gas Chromatography/Mass Spectrometry with Dynamic Headspace Extraction. Mass Spectrometry, 2015, 4(1), A0034–A0034.